Sylke Poehling - News - alle Infos bei Yasni.de

(1 - 15 von 17

)

Die Zukunft der Medizin liegt in unseren Genen - Roche.dewww.roche.de › aktuelles › stories › die-zukunft-der-medizin-liegt-in-unse...

www.roche.de

· ... zur Produktion von Protein- und Antikörpertherapien gegen chronische Erkrankungen nutzen“, sagt Sylke Poehling, Senior Vice President, ...

Roche and Molecular Partners enter into alliance

www.bionity.com

Roche and Molecular Partners AG announced that they have entered into a research collaboration and licensing agreement to discover, develop and commercialize...

DPharm: Disruptive Clinical Trials US- September , Boston,...

www.thebostoncalendar.com

DPharm is where the clinical trials industry gathers to report on the latest disruptive and innovative projects to advance clinical trials DPharm is...

Roche and Molecular Partners enter into alliance to develop ...

lifesciences.instinctif.com

... is truly complementary to our internal capabilities in the large molecule space,” Sylke Poehling, Head of Large Molecule Research at Roche commented. › r...

Roche and Molecular Partners Enter into Alliance | Technology Networks

www.technologynetworks.com

Partnership will combine novel biologics with Roche drug-conjugate technology to develop new cancer treatments.

Roche and Molecular Partners collaborate to develop new ...www.manufacturingchemist.com › ...

www.manufacturingchemist.com

... complementary to our internal capabilities in the large molecule space,' said Sylke Poehling, Head of Large Molecule Research at Roche.

DPharm: Disruptive Clinical Trials US - September ,2018

www.frontiersin.org

— Co-chairs Dr Sylke Poehling, SVP and Global Head, Strategy, Portfolio and Clinical Operations, Roche, Dr Andreas Koester, VP and Global Head ... › events

Molecular Partners与Roche共同开发癌症药物传递载体_公司动态_行业动态_Roche, Molecular...

www.labbase.net

... our internal capabilities in the large molecule space,” Sylke Poehling, Head of Large Molecule Research at Roche commented. “In the field of ...

Roche and Molecular Partners ally against cancer | Drug Discovery...

www.drugdiscoverynews.com

Partnership will combine novel biologics with drug-conjugate technology

Roche signs $1bn-plus cancer deal with Molecular Partners ...www.pmlive.com › pharma_news

www.pmlive.com

Sylke Poehling, head of Large Molecule Research at Roche, said in a statement that "in the field of drug conjugates, we have identified an ...

Roche, Molecular Partners Launch $1B+ Cancer Drug Alliance

www.genengnews.com

— ... to our internal capabilities in the large molecule space,” Sylke Poehling, Roche's head of large molecule research, said in a statement. › tra...

Roche, Molecular Partners in cancer deal worth over $1 billion -

pharmaphorum.com

— Sylke Poehling, Head of Large Molecule Research at Roche. “Roche is one of the top players in oncology and specifically the toxic payload ... › news